Giving Process Its Due When An SDO Changes Rules Of The Game 22/01/2017 by Intellectual Property Watch 1 Comment George Willingmyre writes: The process a Standards Developing Organization (SDO) employs to revise its patent policy is an aspect of the SDO’s competitive posture in the global marketplace. A dearth of research exists on the processes SDOs employ to revise their patent policies. Generally, the processes an SDO uses to revise its patent policy are part of the governance processes of the SDO. As a baseline, the governance processes of an SDO must be consistent with the applicable legal system defining what is acceptable and unacceptable behavior. What an SDO says about its governance processes is a further consideration. Thus the procedures themselves, the procedures’ relationship to the applicable legal system and what the SDO says about the procedures all play a role in understanding how an SDO revises its patent policy.
IP Law In The US: A Look Ahead 20/01/2017 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Whatever else could be said of 2016, it was undeniably interesting. That’s likely to be true, too, for 2017. Even the staid area of US Intellectual Property Law may face dramatic changes. Here’s the likely most important of those changes.
WHO Board Meeting Playbook: Election Of New DG, Antimicrobial Resistance, Genetic Sequence Data 17/01/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Although the main governing body of the World Health Organization is the annual World Health Assembly held in May, many decisions are made at the annual January session of the WHO Executive Board. Among the topics to be discussed next week are the election of a new director general, antimicrobial resistance, the financing of research and development for health products.
New Book Highlights IP Trade Law Flexibilities For Public Health 16/01/2017 by William New, Intellectual Property Watch Leave a Comment A recently published book by a high-impact public health advocate provides new analysis on the use of flexibilities in international trade law relating to intellectual property rights aimed at advancing discussions on solutions to high drug prices worldwide.
Book Review: Interactions Of Climate Change And The Global IP System 10/01/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Climate change is prompting the need for new technologies to address the consequences of the weather changing patterns. A book authored by a number of scholars provides an introduction to the interactions of climate change with the global intellectual property, innovation, human rights and international trade systems.
Expensive Medicines Increase The Pressure 09/01/2017 by Intellectual Property Watch 1 Comment When Gilead brought its new antiviral medicine – Sovaldi – for the treatment of Hepatitis C to the US market for USD 84,000, it triggered a storm of protest. Demand for this revolutionary treatment was so high that the price (despite reductions) became an enormous burden on the American healthcare system. Although the product is cheaper in Switzerland at CHF 48 307, treatment is rationed for reasons of cost.
Book Review: A Look At Antitrust Issues In Intellectual Property Law 09/01/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The book Antitrust Issues in Intellectual Property Law, edited by Bradford Lyerla and authored by several lawyers, is about the intersection of IP law and antitrust law and collects case law from 2015 and 20152016??, dealing with the issue.
IP World Enters New Year With Major Shift Of People In Pharma, Copyright 22/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment As a new year dawns, a lot of movement has been observed in the pharmaceutical industry with new key players taking the lead. Meanwhile, new delegates are covering IP issues in Geneva, and coordination of regional groups at the World Intellectual Property Organization makes its usual yearly shift for 2017. The copyright industry also saw major changes, and law offices have been busy hiring new partners.
US Supreme Court Eyes Patent-Enforced Post-Sale Restrictions 21/12/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Few were surprised when, earlier this month, the US Supreme Court agreed to hear the appeal in Impression Products, Inc. v. Lexmark International. The case presents two important patent law issues, and the lower court’s ruling on these issues conflicts with Supreme Court precedents, according to many experts.
UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research 13/12/2016 by Alexandra Nightingale for Intellectual Property Watch 1 Comment From extracurricular creativity to global campaigns, Universities Allied for Essential Medicines (UAEM) continues in its activities to raise awareness and explore how universities can best direct their research and innovations towards promoting global access to medicines. In the next year, UAEM will extend its national and international campaigns to address the high prices of medicines, continue to gather support for a global agreement on research and development and build on the mapping alternative R&D initiatives.